Login or sign up
For business

Modulation therapeutics

4.1· 11 reviews
Average ratingGreat
4.1/ 5

Based on 11 reviews

536%
436%
327%
20%
10%
Kristina Liphardt
Reviews 1

Modulation Therapeutics is an amazing company. I am really impressed with their services. The website is easy to navigate and provides all the necessary information. The customer service team is very responsive and helpful. I would highly recommend them to anyone.

Arkadiusz Ziemba
Reviews 1

I had a great experience with Modulation Therapeautics! Their website was easy to navigate and provided all the information I needed. The customer service was excellent, with fast response times and helpful answers to all my questions. I would highly recommend Modulation Therapeutics to anyone in need of their services.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Modulation therapeutics

Modulation Therapeutics is dedicated towards the rapid and cost effective advancement of early stage first in class molecules targeting the tumor microenvironment. Tumors that home or metastasize to the bone are typically difficult to treat with standard chemotherapy. We propose that strategies to eradicate tumors that home or metastasize to the bone marrow compartment must include disrupting tumor-host interactions. Our lead compound MTI-101 targets CD44, a cell adhesion molecule required for homing to the bone. Our compound shows activity as a single agent using myeloma in vivo models. We project IND filing of our lead compound MTI-101 in the fourth quarter of 2013. Our goal is to develop the lead compound for the treatment of Myeloma a plasma cell tumor which homes to the bone and a disease which currently has no curative therapies available

Address
3802 spectrum boulevard
Categories
Pharmaceuticals